As reported by InPharm, the global pharmaceutical company GlaxoSmithKline (GSK) are to enter a 5 year partnership with Dundee University and the Wellcome Trust to develop new drugs for neglected tropical diseases.
The Wellcome Trust has donated £10million to the drug discovery unit at Dundee University to help support the partnership. This unit will then work with GSK’s kineoplastids discovery performance at their site based in Spain.
The aim of the project is develop at least one treatment against one of the tropical diseases (which include Chagas disease, leishmaniasis and African sleeping sickness) within the next 5 years. These diseases kill tens of thousands of people across the developing world each year and are often caused by parasites called kinetoplastids.